Hepatitis Forums

Hepatitis C Main Forums => Hepatitis C Research News & Studies => Topic started by: iana5252 on November 26, 2013, 09:14:55 am

Title: FDA Approves New Hep C Drug: Olysio (Simeprevir)
Post by: iana5252 on November 26, 2013, 09:14:55 am

The U.S. Food and Drug Administration (FDA) has approved Janssen Therapeutics’ NS3/4A protease inhibitor Olysio (simeprevir) for the treatment of those with genotype 1 of hepatitis C virus (HCV) who have compensated liver disease, including cirrhosis. People who are treatment naive as well as those who have failed a previous attempt at a hep C cure may benefit from the drug, which is to be taken in combination with pegylated interferon and ribavirin.

http://www.hepmag.com/articles/Olysio_simeprevir_2501_24839.shtml

Next up is Sovaldi (sofosbuvir). Hopefully in the next week or two.

Title: Re: FDA Approves New Hep C Drug: Olysio (Simeprevir)
Post by: jberlin on November 30, 2013, 01:19:27 am

They are making such great strides, and this is more welcome news, but soon I hope we will have our 1st regimen that will not include interferon.  Fingers crossed. -jack